Close

Abbott (ABT) Lower as Merger Partner St. Jude (STJ) Hit with Short Report

Go back to Abbott (ABT) Lower as Merger Partner St. Jude (STJ) Hit with Short Report

Credit Suisse Assesses St. Jude Medical (STJ) Risk; Says Product Removal Unlikely But Could Be Grounds for Abbott to Exit or Lower Bid

August 26, 2016 7:28 AM EDT

Credit Suisse analyst Matthew Keeler assessed the risk surrounding St. Jude Medical (NYSE: STJ) after Muddy Waters issued a new short report yesterday, highlighting cybersecurity risk to the company's cardiac rhythm management (CRM) remote monitoring system.

Keeler notes St. Jude Medical has not provided any detailed commentary on the matter and they expect shares to remain under pressure until it does so. While they have been unable to assess the risk... More

St. Jude Medical (STJ) Sell-Off Intensifies on Worries Over Merger Amid Short Report

August 25, 2016 11:47 AM EDT

The sell-off in St. Jude Medical (NYSE: STJ) is intensifying following the earlier Muddy Waters shorts report. Concerns about the pending merger with Abbott are now front and center. Shares are now down 8%.

... More

Abbott (ABT) won't comment on St. Jude Medical (STH) short report - Bloomberg

August 25, 2016 11:38 AM EDT

Abbott (NYSE: ABT) won't comment on St. Jude Medical (NYSE: STJ) short report from Citron Research, according o Bloomberg.

... More